Amphastar P (AMPH)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	489,600	543,005	384,554	407,670	378,319	384,222	377,145	364,415	318,119	303,671	310,973	300,164	279,682	276,541	266,821	246,724	255,241	268,903	284,134	230,143
Total current liabilities	US$ in thousands	225,407	257,963	251,285	105,635	94,862	102,190	103,634	114,364	103,810	97,989	124,549	127,096	112,201	96,717	93,286	83,371	90,009	86,596	100,999	111,959
Current ratio		2.17	2.10	1.53	3.86	3.99	3.76	3.64	3.19	3.06	3.10	2.50	2.36	2.49	2.86	2.86	2.96	2.84	3.11	2.81	2.06

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $489,600K ÷ $225,407K
= 2.17

The current ratio of Amphastar Pharmaceuticals Inc has exhibited fluctuating trends over the past eight quarters. The ratio has varied from a low of 1.53 in Q2 2023 to a high of 3.99 in Q4 2022. The current ratio measures the company's ability to meet its short-term financial obligations using its current assets. A higher current ratio is generally seen as favorable as it indicates that the company can easily cover its short-term liabilities.

In the most recent quarter, Q4 2023, the current ratio stood at 2.17, showing a decrease from the previous quarter but still indicating that the company has more than enough current assets to cover its current liabilities. It is important to note that a current ratio above 1.0 signifies the company has more current assets than current liabilities.

Overall, while there have been fluctuations in the current ratio of Amphastar Pharmaceuticals Inc, the ratios over the past eight quarters suggest that the company has generally maintained a healthy liquidity position and has been able to meet its short-term obligations effectively.